Increasing competitiveness and increasing the influence of Bowl Biotech by entering new international outlets through the realisation of investments related to the launch of the production of new implants for the manufacture of implants, which is the result of own research and development (R & D) activities. (Q120896): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Created claim: summary (P836): The project aims to increase the competitiveness of Bowl Biotech and improve its capacity to develop products through innovation. The project relates to the carrying out of investments in tangible assets linked to the production of a production line existing at the factory bionanoceululose of the company. As a result of the investment, the firm will be able to produce bio-material that will be used for the manufacture of class III medical device...) |
||
| Property / summary | |||
The project aims to increase the competitiveness of Bowl Biotech and improve its capacity to develop products through innovation. The project relates to the carrying out of investments in tangible assets linked to the production of a production line existing at the factory bionanoceululose of the company. As a result of the investment, the firm will be able to produce bio-material that will be used for the manufacture of class III medical devices for neurosurgery, vascular surgery and cardiac surgery. The project will result in a new, innovative global material that will enable the company to expand its new product segment, expand its exports and extend its impact to new foreign markets — the US. The product entering into the product is the result of its own research and development (R & D) carried out in the framework of the PBS “cardio BNC” project and its presence on the market will make an important contribution to the development of regenerative medicine and medical genetics. (English) | |||
| Property / summary: The project aims to increase the competitiveness of Bowl Biotech and improve its capacity to develop products through innovation. The project relates to the carrying out of investments in tangible assets linked to the production of a production line existing at the factory bionanoceululose of the company. As a result of the investment, the firm will be able to produce bio-material that will be used for the manufacture of class III medical devices for neurosurgery, vascular surgery and cardiac surgery. The project will result in a new, innovative global material that will enable the company to expand its new product segment, expand its exports and extend its impact to new foreign markets — the US. The product entering into the product is the result of its own research and development (R & D) carried out in the framework of the PBS “cardio BNC” project and its presence on the market will make an important contribution to the development of regenerative medicine and medical genetics. (English) / rank | |||
Normal rank | |||
Revision as of 10:10, 10 March 2020
Project in Poland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Increasing competitiveness and increasing the influence of Bowl Biotech by entering new international outlets through the realisation of investments related to the launch of the production of new implants for the manufacture of implants, which is the result of own research and development (R & D) activities. |
Project in Poland financed by DG Regio |
Statements
996,332.13 zloty
0 references
2,421,000.75 zloty
0 references
49.99 percent
0 references
1 June 2016
0 references
31 December 2018
0 references
BOWIL BIOTECH SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
0 references
Celem projektu jest wzrost konkurencyjności Bowil Biotech i poprawa jej zdolności do rozwijania produktów poprzez zastosowanie innowacji. Projekt dotyczy przeprowadzenia inwestycji w rzeczowe środki trwałe związane z upgradem linii produkcyjnej istniejącej w fabryce bionanocelulozy spółki. W wyniku realizacji inwestycji firma osiągnie możliwość produkcyjną wytwarzania biomateriału, który znajdzie zastosowanie w produkcji wyrobów medycznych klasy III jakim są bioimplanty dla neurochirurgii, chirurgii naczyniowej i kardiochirurgii. Efektem realizacji projektu będzie nowy, innowacyjny w skali świata materiał, który umożliwi firmie ekspansję nowego segmentu produktowego, rozwój eksportu i rozszerzenie swojego oddziaływania o nowe rynki zagraniczne - USA. Wprowadzany produkt jest wynikiem własnych prac badawczo-rozwojowych, zrealizowanych w ramach projektu PBS „Kardio BNC” i jego zaistnienie na rynku spowoduje istotny wkład w rozwój medycyny regeneracyjnej i implantologii. (Polish)
0 references
The project aims to increase the competitiveness of Bowl Biotech and improve its capacity to develop products through innovation. The project relates to the carrying out of investments in tangible assets linked to the production of a production line existing at the factory bionanoceululose of the company. As a result of the investment, the firm will be able to produce bio-material that will be used for the manufacture of class III medical devices for neurosurgery, vascular surgery and cardiac surgery. The project will result in a new, innovative global material that will enable the company to expand its new product segment, expand its exports and extend its impact to new foreign markets — the US. The product entering into the product is the result of its own research and development (R & D) carried out in the framework of the PBS “cardio BNC” project and its presence on the market will make an important contribution to the development of regenerative medicine and medical genetics. (English)
0 references
Identifiers
RPPM.02.02.01-22-0122/16
0 references